1354964-58-1

Basic information

• Product Name: (Z)-2-(2-(4-(3,4-dichlorophenyl)thiazol-2-yl)hydrazono)-2-(2-nitrophenyl)acetic acid
• Synonyms: (Z)-2-(2-(4-(3,4-dichlorophenyl)thiazol-2-yl)hydrazono)-2-(2-nitrophenyl)acetic acid
• CAS NO: 1354964-58-1
• Molecular Weight: 437.263
• Mol File: 1354964-58-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (Z)-2-(2-(4-(3,4-dichlorophenyl)thiazol-2-yl)hydrazono)-2-(2-nitrophenyl)acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (Z)-2-(2-(4-(3,4-dichlorophenyl)thiazol-2-yl)hydrazono)-2-(2-nitrophenyl)acetic acid(1354964-58-1)
• EPA Substance Registry System: (Z)-2-(2-(4-(3,4-dichlorophenyl)thiazol-2-yl)hydrazono)-2-(2-nitrophenyl)acetic acid(1354964-58-1)

Safety Data

• Hazardous Substances Data: 1354964-58-1(Hazardous Substances Data)

Upstream product

• 312303-66-5 4-(3,4-dichloro-phenyl)-thiazol-2-yl-hydrazine 
• 610-33-3 (2-nitro-phenyl)-glyoxylic acid 
• 67603-23-0 o-nitromandelic acid 
• 13312-81-7 2-hydroxy-2-[2-nitrophenyl]acetonitrile 
• 552-89-6 2-nitro-benzaldehyde 

Relevant articles and documents

COMPOUNDS FOR THE INHIBITION OF CELLULAR PROLIFERATION

Compositions and methods for inhibiting translation are provided. Compositions, methods and kits for treating (1) cellular proliferative disorders, (2) non-proliferative, degenerative disorders, (3) viral infections, (4) disorders associated with viral infections, and/or (5) non-proliferative metabolic disorders such as type II diabetes where inhibition of translation initiation is beneficial using the compounds disclosed herein.